Science 37 Holdings, Inc.
SNCEInactive ticker- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001819113
No open-market purchases or sales by Science 37 Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
This ticker is no longer on the SEC's list of tickers: the company may have been delisted, or the ticker has changed.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Science 37 Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Science 37 Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder Holdings III | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Spectra-Physics Holdings USA, LLC | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder Holdings I | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder Holdings II | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Fisher Scientific Worldwide Inc. | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Fisher Scientific International LLC | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Pharmaceutical Product Development, LLC | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Jaguar Holding Co I, LLC | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Wildcat Acquisition Holdings (UK) Ltd | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Eagle Holding Co II, LLC | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Jaguar Holding Co II | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| PPD, Inc. | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder US Holdings Corp. | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder Holdings IV | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Thermo Fisher Scientific Powder US Holdings Ltd | 10% Owner | 0Indirect | Mar 14, 2024 | 0 |
| Redmile Group, LLC | Other: Former 10% Owner and Director | 0Indirect | Mar 13, 2024 | 0 |
| Green Jeremy | Other: Former 10% Owner and Director | 0Indirect | Mar 13, 2024 | 0 |
| Faulkner Robert C. | Other: Former Director | 0 | Mar 13, 2024 | 0 |
| Pellizzari Christine A | Chief Legal and HR Officer | 0 | Mar 12, 2024 | 0 |
| von Autenried Paul | Other: Former Director | 0 | Mar 12, 2024 | 0 |
| Hubbard John W | Other: Former Director | 0 | Mar 12, 2024 | 0 |
| Rollins Emily | Other: Former Director | 0 | Mar 12, 2024 | 0 |
| Zaranek Mike | Chief Financial Officer | 0 | Mar 12, 2024 | 0 |
| Cotliar Jonathan | Chief Medical Officer | 0 | Mar 12, 2024 | 0 |
| Coman David | Chief Executive Officer | 0 | Mar 12, 2024 | 0 |
| Forman Darcy | Chief Delivery Officer | 0 | Mar 12, 2024 | 0 |
| Tiwari Neil | Other: Former Director | 0 | Mar 12, 2024 | 0 |
| Shipton Michael | Chief Commercial Officer | 0 | Mar 12, 2024 | 0 |
| Bryenton Troy | Chief Technology Officer | – | May 12, 2023 | 0 |
| Geffon Steven | Chief Commercial Officer | – | Aug 16, 2022 | 0 |
| Goulburn Adam | Director | 2,481 | May 24, 2022 | 0 |
| Lux Capital Management, LLC | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Lux Ventures IV, L.P. | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Lux Venture Partners IV, LLC | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Hebert Peter | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Lux Co-Invest Partners, LLC | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Lux Co-Invest Opportunities, L.P. | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| Wolfe Josh | 10% Owner | 8,743,999Indirect | Apr 6, 2022 | 0 |
| McDonald Andrew I | Chief Executive Officer | 1,772,034Indirect | Aug 26, 2021 | 0 |
| Rice Michael Yehuda | Chief Operating Officer | 1,772,034Indirect | Aug 26, 2021 | 0 |
| LifeSci Holdings LLC | 10% Owner | 1,772,034 | Aug 26, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 (view filing) | Nov 17 | Same day | Pellizzari Christine AChief Legal Officer | PPurchase | +5.00K | $0.81 | +$4.05K | New position5.00K after |